Daniel L. Kisner, Director at Oncternal Therapeutics, Inc. (ONCT), bought 10,000 shares at $2.38 ($24K) on 2020-07-21, disclosed to the SEC on 2020-07-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| CNAT | BUY | 2015-04-10 | $23K | — | Filing → |
| DVAX | BUY | 2013-10-30 | $11K | — | Filing → |
| CALP | SELL | 2008-06-05 | $4K | — | Filing → |